StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > New Press Release - StageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022

<< Previous

Bullboard Posts

Next >>

Comment by brad129on Nov 11, 2022 11:22pm

85 Views

Post# 35093202

RE:RE:RE:RE:RE:New Press Release - StageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022

Things are different now, they weren't that far from being cash positive last report. I believe they hit it now and if they did you might disappointed.

Liked2Think wrote:

be prepared for a disappointment

it's the stage way

brad129 wrote:

Cash flow positive baby, that's how come on Tripp time to show the magic.

Nailbiter2 wrote: Burning a hole in me man.

LithLover wrote: I'm curious how they ran for 4.5 months (July 1-Nov 15)
and counting on 267k cash.

PressRelease wrote:
TORONTO, ON / ACCESSWIRE / November 11, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its third quarter operational and financial results before the markets open on Tuesday, November 15, 2022. StageZero's Chairman and CEO, James...read article.